Connection

Angelina Passaro to Humans

This is a "connection" page, showing publications Angelina Passaro has written about Humans.
Connection Strength

0.163
  1. Bowel ischemia as onset of COVID-19 in otherwise asymptomatic patients with persistently negative swab. J Intern Med. 2022 02; 291(2):224-231.
    View in: PubMed
    Score: 0.008
  2. Reply Letter - SARS-CoV-2 infection and H1N1 vaccination: does a relationship between the two factors really exist? A retrospective analysis of a territorial cohort in Ferrara, Italy. Eur Rev Med Pharmacol Sci. 2021 05; 25(9):3403-3404.
    View in: PubMed
    Score: 0.008
  3. Role of Statins in Coronavirus-Related Disease (COVID-19): A Retrospective Cohort Study in Northern Italy. High Blood Press Cardiovasc Prev. 2021 Jul; 28(4):355-364.
    View in: PubMed
    Score: 0.008
  4. Severity of COVID-19 in patients with lung cancer: evidence and challenges. J Immunother Cancer. 2021 03; 9(3).
    View in: PubMed
    Score: 0.007
  5. SARS-CoV-2 infection and H1N1 vaccination: does a relationship between the two factors really exist? A retrospective analysis of a territorial cohort in Ferrara, Italy. Eur Rev Med Pharmacol Sci. 2021 Mar; 25(6):2795-2801.
    View in: PubMed
    Score: 0.007
  6. SARS-CoV-2 and finding of vein thrombosis: can IMPROVE and IMPROVEDD scores predict COVID-19 outcomes? Eur Rev Med Pharmacol Sci. 2021 Feb; 25(4):2123-2130.
    View in: PubMed
    Score: 0.007
  7. SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient. Clin Microbiol Infect. 2021 Jun; 27(6):936-937.
    View in: PubMed
    Score: 0.007
  8. ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer. ESMO Open. 2020 06; 5(Suppl 3).
    View in: PubMed
    Score: 0.007
  9. Testing for COVID-19 in lung cancer patients. Ann Oncol. 2020 07; 31(7):832-834.
    View in: PubMed
    Score: 0.007
  10. Immunotherapy in Non-Small-Cell Lung Cancer Patients With Performance Status 2: Clinical Decision Making With Scant Evidence. J Clin Oncol. 2019 08 01; 37(22):1863-1867.
    View in: PubMed
    Score: 0.007
  11. Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations. Clin Lung Cancer. 2019 03; 20(2):e186-e194.
    View in: PubMed
    Score: 0.006
  12. Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes. Oxid Med Cell Longev. 2018; 2018:1752940.
    View in: PubMed
    Score: 0.006
  13. Immunotherapy in refractory SCLC: the caterpillar struggling to become a butterfly. Pulmonology. 2018 Nov - Dec; 24(6):321-322.
    View in: PubMed
    Score: 0.006
  14. Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation. BMC Infect Dis. 2018 01 05; 18(1):10.
    View in: PubMed
    Score: 0.006
  15. Brigatinib for the treatment of ALK-positive advanced non-small cell lung cancer patients. Drugs Today (Barc). 2017 Aug; 53(8):435-446.
    View in: PubMed
    Score: 0.006
  16. Gene expression regional differences in human subcutaneous adipose tissue. BMC Genomics. 2017 02 23; 18(1):202.
    View in: PubMed
    Score: 0.006
  17. Computerized cognitive training and brain derived neurotrophic factor during bed rest: mechanisms to protect individual during acute stress. Aging (Albany NY). 2017 02 03; 9(2):393-407.
    View in: PubMed
    Score: 0.006
  18. Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatment. Pharmacol Res. 2017 03; 117:406-415.
    View in: PubMed
    Score: 0.006
  19. COVID-19 inpatients with gastrointestinal onset: sex and care needs' differences in the district of Ferrara, Italy. BMC Infect Dis. 2021 Aug 03; 21(1):739.
    View in: PubMed
    Score: 0.002
  20. Rethinking of osteoporosis through a sex- and gender-informed approach in the COVID-19 era. Minerva Obstet Gynecol. 2021 Dec; 73(6):754-769.
    View in: PubMed
    Score: 0.002
  21. Is venous thromboembolism a predictable marker in older patients with COVID-19 infection? A single-center observational study. J Infect Dev Ctries. 2021 05 31; 15(5):639-345.
    View in: PubMed
    Score: 0.002
  22. Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. JAMA Intern Med. 2021 01 01; 181(1):24-31.
    View in: PubMed
    Score: 0.002
  23. Prediction of in-hospital mortality of patients with SARS-CoV-2 infection by comorbidity indexes: an Italian internal medicine single center study. Eur Rev Med Pharmacol Sci. 2020 Oct; 24(19):10258-10266.
    View in: PubMed
    Score: 0.002
  24. SARS-CoV-2 RNA contamination on surfaces of a COVID-19 ward in a hospital of Northern Italy: what risk of transmission? Eur Rev Med Pharmacol Sci. 2020 09; 24(17):9202-9207.
    View in: PubMed
    Score: 0.002
  25. Morning vs. evening administration of antiviral therapy in COVID-19 patients. A preliminary retrospective study in Ferrara, Italy. Eur Rev Med Pharmacol Sci. 2020 08; 24(15):8219-8225.
    View in: PubMed
    Score: 0.002
  26. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020 07; 21(7):914-922.
    View in: PubMed
    Score: 0.002
  27. Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective. ESMO Open. 2020 03; 5(2).
    View in: PubMed
    Score: 0.002
  28. The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels. Front Immunol. 2019; 10:793.
    View in: PubMed
    Score: 0.002
  29. Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer's Disease. Dis Markers. 2018; 2018:2576026.
    View in: PubMed
    Score: 0.002
  30. The immune profile of EGFR-mutated non-small-cell lung cancer at disease onset and progression after tyrosine kinase inhibitors therapy. Immunotherapy. 2018 09; 10(12):1041-1045.
    View in: PubMed
    Score: 0.002
  31. TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress. Mediators Inflamm. 2018; 2018:9629537.
    View in: PubMed
    Score: 0.002
  32. EGFR-TKIs in non-small-cell lung cancer: focus on clinical pharmacology and mechanisms of resistance. Pharmacogenomics. 2018 06 01; 19(8):727-740.
    View in: PubMed
    Score: 0.002
  33. Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer's Disease. Gerontology. 2018; 64(5):414-421.
    View in: PubMed
    Score: 0.002
  34. Acquired Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers: The Role of Next-Generation Sequencing on Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples. Arch Pathol Lab Med. 2018 Apr; 142(4):465-473.
    View in: PubMed
    Score: 0.002
  35. The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics. J Clin Pathol. 2018 Sep; 71(9):767-773.
    View in: PubMed
    Score: 0.002
  36. Effects of 14 days of bed rest and following physical training on metabolic cost, mechanical work, and efficiency during walking in older and young healthy males. PLoS One. 2018; 13(3):e0194291.
    View in: PubMed
    Score: 0.002
  37. Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia. Geroscience. 2018 02; 40(1):61-69.
    View in: PubMed
    Score: 0.002
  38. Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells. Stem Cells. 2018 05; 36(5):633-640.
    View in: PubMed
    Score: 0.002
  39. Loss of maximal explosive power of lower limbs after 2 weeks of disuse and incomplete recovery after retraining in older adults. J Physiol. 2018 02 15; 596(4):647-665.
    View in: PubMed
    Score: 0.002
  40. Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women. Scand J Clin Lab Invest. 2018 Feb - Apr; 78(1-2):18-24.
    View in: PubMed
    Score: 0.001
  41. Lung Tissue Injury as an Atypical Response to Nivolumab in Non-Small Cell Lung Cancer. Am J Respir Crit Care Med. 2017 Nov 15; 196(10):1349-1350.
    View in: PubMed
    Score: 0.001
  42. Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer. Future Oncol. 2018 Feb; 14(4):353-361.
    View in: PubMed
    Score: 0.001
  43. Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs? Crit Rev Oncol Hematol. 2017 Nov; 119:30-39.
    View in: PubMed
    Score: 0.001
  44. Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC. J Natl Cancer Inst. 2017 09 01; 109(9).
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.